Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
companion diagnostic
MedTech
FDA OKs companion Dx with BioMarin hemophilia gene therapy
The FDA’s approval for BioMarin’s Roctavian came with a second greenlight: for a companion diagnostic to identify patients best served by the drug.
Andrea Park
Jun 30, 2023 10:35am
FDA OKs Foundation Medicine's companion Dx for Pfizer's Braftovi
Jun 9, 2023 1:08pm
Roche nets FDA approval for HER2-low breast cancer test
Oct 5, 2022 11:30am
Foundation Medicine nabs yet another companion diagnostic nod
Jun 9, 2022 10:55am
Illumina claims European CDx approval for Bayer rare cancer drug
May 24, 2022 11:37am
AstraZeneca re-ups ties with Chinese cancer test maker AmoyDx
Apr 18, 2022 10:42am